3 ms·
There is a big problem with these artificial "behavioural economics" studies (and it's a known issue that lab based decisions differ from real life). But claim
by lifeisstillgood 12y ago
There is a big problem with these artificial "behavioural economics" studies (and it's a known issue that lab based decisions differ from real life).
But claiming that people have bad risk management (scenario : do you want the blue pill (risk of death 1/1000 or the red pill (2/1000). People pay upto 200 extra for blue pill. Or will you take part in testing the red pill for FDA (people refuse 50k to take part)
Here you are not comparing loss aversion to a 1/1000 chance - you are comparing "safe and tested pills" versus joining a human drug trial. Even non statisticians can tell we don't know that's a 1/1000 chance
So I do worry about basing predictions about VCs on poorly understood loss aversion from reports of studies that leave much to be desired.
- diminoten 12y agoI wish they would have picked a less dramatic consequence. Death as a consequence forces me to mitigate risk to the highest degree I know how to, which I think would skew the results, if folks are anything like me. Death is just so final, and such a significantly different force in the lives of humans, that it can't really be compared to anything else.
- meric 12y agoLoss of one's descendants. Imagine a grandfather losing all their children and their grandchildren in a flight crash.
- Falkon1313 12y agoThe point is that people are told that the risk of death is the same in both cases, and either way, they're deciding between the same chance of loss of life, or certain loss of money, but they respond differently depending on how it is phrased - whether they would be losing or gaining the money in exchange for taking (or not taking) the risk. What I see as the inequivalence is that in the first case, they're gaining a cure either way (if it doesn't kill them). (Although it doesn't say what would be cured - I wonder whether most people assumed a terminal illness vs. some minor ailment?) But in the second scenario, they're not gaining anything but the money. So it becomes a 99.9% chance of curing something that you want to cure (possibly terminal) vs a 0.1% chance of dying for nothing but money when you weren't even sick. I wonder if death isn't the biggest skew though. When pharmaceuticals are mentioned, I think of weight loss, impotence, and cosmetics industries. It would be interesting to see the outcome of replicating the experiment for each of those compared to actual industry profits of each. If a group of people pay more to try to be attractive than they do to delay death, would their experimental responses to risk match the observed facts of their actual behavior? Are most people acting irrationally (in the Economics sense)? And if so, what would that tell us about the risk studies?